Ursprung des Netzwerks ersten Grades von Katsuyoshi Sugita
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 40 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Katsuyoshi Sugita
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
PIONEER CORP | Electronic Production Equipment | Director of Finance/CFO | |
Universal Cells, Inc.
Universal Cells, Inc. BiotechnologyHealth Technology Universal Cells, Inc. develops, licenses and commercializes stem cell therapies. The company was founded by Claudia Mitchell and David Russell and is headquartered in Seattle, WA. | Biotechnology | Chief Executive Officer | |
KAO CORPORATION | Household/Personal Care | Director/Board Member | |
HITACHI KOKI CO., LTD. | Electrical Products | Comptroller/Controller/Auditor | |
INABATA & CO.,LTD. | Wholesale Distributors | Director/Board Member | |
TAMURA CORPORATION | Electronic Components | Director/Board Member | |
NICHIREKI CO., LTD. | Engineering & Construction | Director/Board Member | |
Keio University | College/University | Undergraduate Degree Doctorate Degree | |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Waseda University | College/University | Corporate Officer/Principal | |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Pharmaceuticals: Major | Chief Executive Officer General Counsel Corporate Officer/Principal | |
Astellas Venture Management LLC
Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Phrama Inc founded in 2000. The firm is headquartered in Brisbane, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
University of Hitotsubashi | College/University | Masters Business Admin | |
University of Tokyo | College/University | Graduate Degree Doctorate Degree | |
FREEBIT CO., LTD. | Internet Software/Services | Founder | |
Kanazawa University | College/University | Doctorate Degree | |
Tokyo Institute of Technology | College/University | Doctorate Degree | |
Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
SKYLARK HOLDINGS CO., LTD. | Restaurants | Director of Finance/CFO | |
The U.S.-Japan Business Council, Inc. | Director/Board Member | ||
Fanatics LLC
Fanatics LLC Internet Software/ServicesTechnology Services Fanatics LLC retails sports apparel and merchandise. Its brands include Nike, Adidas, Under Armour, Fanatics, Starter, Kitbag, Majestic and Columbia. The company was founded by Alan S. Trager, Michael Rubin, and Mitchell Trager in 2002 and is headquartered in Jacksonville, FL. | Internet Software/Services | Chief Tech/Sci/R&D Officer | |
French-American Chamber of Commerce
French-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The French-American Chamber of Commerce (FACC) is a non-profit, member-driven organization founded in 1985. The non-profit company is based in Atlanta, GA. The FACC is part of a network of 18 French-American chambers representing over 5,000 companies nationwide in all major industries. The company is also a proud member of CCI International, an international network of 124 French chambers of commerce in 95 countries, representing over 37,000 members worldwide. The FACC's mission is to promote, support, and enhance business opportunities among the French-American business community throughout the Southeast of the United States. The company provides opportunities for members to network, connect, collaborate, and learn from one another through events and programs. The FACC is the main professional forum and business resource for French companies and their leaders doing business in and with the Southeast of the United States, and for companies in the Southeast of the United States doing business in and with France. The company also provides a range of trade services to their local members and to French businesses and entrepreneurs seeking to develop their business in the Southeast of the United States. | Miscellaneous Commercial Services | Director/Board Member | |
Washington Biotechnology & Biomedical Association | Director/Board Member | ||
Astellas US LLC
Astellas US LLC Pharmaceuticals: MajorHealth Technology Part of Astellas Pharma, Inc., Astellas US LLC is a company that manufactures and markets pharmaceutical products. The company is based in Northbrook, IL. The CEO of the company is Kenji Yasukawa. | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
Dow Corning Holding Japan KK
Dow Corning Holding Japan KK Financial ConglomeratesFinance Part of Dow, Inc., Dow Corning Holding Japan KK is an investment holding Japanese company. | Financial Conglomerates | President | |
Dow Corning Toray Co. Ltd.
Dow Corning Toray Co. Ltd. Industrial SpecialtiesProcess Industries Part of Dow, Inc., Dow Corning Toray Co. Ltd. is a Japanese company that manufactures rubber, chemical and film products. The company is based in Tokyo, Japan. Eriko Sakurai has been the CEO of the company since 2008. | Industrial Specialties | Chief Executive Officer | |
ADOCIA | Pharmaceuticals: Major | Director/Board Member | |
Homma & Partners | Corporate Officer/Principal | ||
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
JAPAN DISPLAY INC. | Electronic Components | Chief Executive Officer | |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Halo-Bio RNAi Therapeutics, Inc.
Halo-Bio RNAi Therapeutics, Inc. BiotechnologyHealth Technology Halo-Bio RNAi Therapeutics, Inc. utilizes the novel 'Multivalent RNAi Platform' to develop multi-gene targeting products for the treatment of disease. The firm specializes in RNAi, Biopharmaceuticals, RNA Delivery and Nanoparticles. The company is headquartered in Seattle, WA. | Biotechnology | Founder | |
Astellas Pharma Ltd.
Astellas Pharma Ltd. Internet Software/ServicesTechnology Services Astellas Pharma Ltd. provides an online directory services for the pharmaceutical industry. The firm wholesales pharmaceutical goods. The company was founded on January 10, 1964 and is headquartered in West Byfleet, the United Kingdom. | Internet Software/Services | Director/Board Member | |
Foundation for Promotion of Medical Training | Chairman | ||
Kyushu University Faculty of Law | College/University | Graduate Degree | |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
DigiTx Partners LLC
DigiTx Partners LLC Investment ManagersFinance DigiTx Partners LLC (DigiTx Partners) is a venture capital firm founded in 2016 by David J. Kim and Luke Evnin. The firm is headquartered in Brisbane, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
Cci France International | Director/Board Member | ||
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member | |
Ecole Des Ponts Business School | College/University | Masters Business Admin | |
Pykus Therapeutics, Inc.
Pykus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Pykus Therapeutics, Inc. engages in the development of a dissolvable intraocular surgical device. It offers novel polymer that provides retinal tamponade. The company was founded by James Stefater and Tomasz Stryjewski and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
TSCAN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
United Immunity Co. Ltd.
United Immunity Co. Ltd. Pharmaceuticals: MajorHealth Technology United Immunity Co. Ltd. is a Japanese company that specializes in pipeline nano technology and immunity fusion technology, specifically in the field of cancer immunotherapy. The company is based in Tsu, Japan and was founded in 2017 by Naozumi Harada, who has been the CEO since then. The company's diverse products, including "nano immunotherapy," have shown promising clinical results and research in the treatment of sex cancer. The company is currently recruiting a researcher in the cancer immunotherapy field to analyze the action mechanism of nanotechnology applied cancer evaluation and drug evaluation using immunological methods. The company's focus is on the development of treatment for the cause of cold tumor type cancer through the understanding of tumor-associated macrophages. | Pharmaceuticals: Major | Director/Board Member | |
Daiwa Securities Health Foundation | Investment Trusts/Mutual Funds | Director/Board Member | |
Universite Paris Cite | College/University | Doctorate Degree | |
Catamaran Bio, Inc.
Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Financial Conglomerates | Director/Board Member | |
Saisei Ventures LLC
Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Reaction Capital
Reaction Capital Investment ManagersFinance Reaction Capital (Reaction) is a venture capital firm founded in 2019. The firm is headquartered in Palo Alto, California. | Investment Managers | Director/Board Member | |
Astellas Pharma China, Inc.
Astellas Pharma China, Inc. Pharmaceuticals: MajorHealth Technology Part of Astellas Pharma, Inc., Astellas Pharma China, Inc. operates a Chinese pharmaceutical company. The company is based in Beijing, China. The company was founded in 1994. The CEO is Hiroshi Kakuguchi. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Japan | 24 |
Vereinigte Staaten | 20 |
Frankreich | 5 |
Vereinigtes Königreich | 3 |
China | 2 |
Sektoral
Health Technology | 14 |
Consumer Services | 11 |
Finance | 7 |
Electronic Technology | 4 |
Commercial Services | 4 |
Operativ
Director/Board Member | 70 |
Corporate Officer/Principal | 34 |
Chairman | 18 |
President | 15 |
Independent Dir/Board Member | 14 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Katsuyoshi Sugita
- Unternehmensverbindungen